IMMURON (IMRN) vs Jaguar Animal Health, Inc. (JAGX)
- IMMURON IMRN 0.98 −4.85%
- Jaguar Animal Health, Inc. JAGX 3.53 −23.09%
IMMURON and Jaguar Animal Health, Inc. are both Biotechnology companies. IMMURON and Jaguar Animal Health, Inc. are of similar size ($8.9M and $8.3M). IMMURON has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against −6.62%. Jaguar Animal Health, Inc. has the higher net margin (−188.5% vs −262.7%) and the lower return on invested capital (−28,393.6% vs 0.00%). Across the 17 metrics below, IMMURON leads on 10 and Jaguar Animal Health, Inc. on 7.
Valuation
Profitability
| Metric | IMRN | JAGX | Biotechnology median |
|---|---|---|---|
| Gross margin | 71.28% | 82.31% | 65.16% |
| Operating margin | 0.00% | (93.10%) | 0.00% |
| Net margin | (262.71%) | (188.46%) | 0.00% |
| Free cash flow margin | 0.00% | (24.03%) | 0.00% |
| Return on equity | 0.00% | (1,125.38%) | (56.36%) |
| Return on assets | 0.00% | (127.14%) | (48.04%) |
| Return on invested capital | 0.00% | (28,393.64%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack